Related Experiment Video
Updated: Jul 5, 2025

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Do patients benefit from omega-3 fatty acids?
Samuel C R Sherratt1,2, R Preston Mason2,3, Peter Libby3
1Department of Molecular, Cellular, and Biomedical Sciences, University of New Hampshire, Durham, NH, USA.
High-dose eicosapentaenoic acid (EPA)-only omega-3 fatty acids (O3FAs) significantly reduce cardiovascular disease events in high-risk patients. Prescription EPA formulations offer greater benefits than mixed EPA/docosahexaenoic acid (DHA) or other O3FAs.
Area of Science:
- Cardiology
- Biochemistry
- Nutritional Science
Background:
- Omega-3 fatty acids (O3FAs) are linked to cardiovascular (CV) health benefits, yet clinical trial results with various O3FA formulations are inconsistent.
- Low-dose eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) mixtures have failed to prevent CV events in primary and secondary prevention.
Approach:
- This review analyzes clinical findings from trials using different O3FA formulations.
- It examines the efficacy of EPA-only versus EPA/DHA or other O3FAs in cardiovascular disease (CVD) prevention.
- Mechanisms of action, including effects on lipids, inflammation, and endothelial function, are discussed.
Key Points:
- EPA-only formulations, like those in JELIS and REDUCE-IT, significantly reduce CVD events in high-risk individuals.
- Achieved EPA levels, not just triglyceride or LDL reduction, correlate with event reduction.
- EPA exhibits distinct biological effects compared to DHA, influencing atherosclerotic plaque, oxidation, and endothelial function.
Conclusions:
- Prescription-grade, EPA-only omega-3 fatty acid formulations demonstrate superior efficacy in reducing cardiovascular events compared to other tested O3FA formulations.
- The unique properties of EPA are crucial for its cardiovascular benefits, independent of broad lipid-lowering effects.
Related Concept Videos
Structure of Lipids
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Lipid-derived Compounds in the Human Body
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
Lipids: Dietary Sources and Requirements
Chronic Pancreatitis II: Collaborative Care
Assessment:
Lifestyle Factors and Health
Benefits of Physical Activity
Physical activity, whether through structured exercise or casual activities like walking, biking, or dancing, is a cornerstone of a...

